TriSalus Life Sciences, Inc.

TriSalus Life Sciences is a U.S.-based medical device company focused on catheter-based infusion systems used in interventional oncology procedures. Its core product platform, TriNav, is designed for delivery in embolization workflows and is sold directly to hospitals, clinics, and physicians in the United States.

−58,3 %

84,6 %

−86,9 %

+53,4 %

2.80

2.54

— TriSalus Life Sciences, Inc.
%
TriNav infusion devices90% Catheter-based infusion devices used in embolization procedures, primarily TriNav.
PEDD infusion systems10% Infusion systems sold for interventional radiology and oncology procedures.

TriSalus sells directly to hospitals, clinics, and ambulatory surgery centers that perform embolization procedures,...

  • Hospitals and academic medical centersprimary

    Buy TriNav for embolization procedures and evaluate it through clinical and procurement committees.

  • Interventional radiologistsprimary

    Use the device in TACE, TARE, and related procedures and influence adoption.

  • Medical oncologists and oncology teamssecondary

    Support treatment planning for liver cancer patients and may recommend use.

  • Ambulatory surgery centers and clinicssecondary

    Purchase devices for outpatient or clinic-based interventional procedures.

  • Value Analysis Committeesprimary

    Review clinical and economic justification before hospital adoption.

TriSalus is headquartered in Westminster, Colorado and sells primarily in the United States through a direct sales...

  • •Headquartered in Westminster, Colorado
  • •Primary market is the United States
  • •Direct sales model reaches hospitals nationwide
  • •Focus on major academic medical centers and procedure-heavy hospitals

TriSalus’ strategy centers on expanding adoption of TriNav among interventional radiologists and hospital systems...

01
Expand TriNav adoption in embolization proceduresshort-term

Procedure volume and physician familiarity drive recurring device usage.

02
Strengthen hospital and clinician relationshipsshort-term

Hospital purchasing depends on clinical trust and committee approval.

03
Support broader interventional oncology positioningmedium-term

Clinical and advocacy relationships can widen awareness and use cases.

TriSalus faces the risks typical of an early-stage medical device company, including customer concentration, limited...

high

Customer termination and weak contractual lock-in

Many agreements are not long-term and some consignment deals can be ended with short notice.

Scope
Hospital and clinic customers
Materiality
high
high

Dependence on physician adoption

Interventional radiologists and hospital committees influence whether TriNav is used.

Scope
Procedure-based demand
Materiality
high
high

Regulatory and reimbursement risk

Device use and hospital economics depend on healthcare regulation and payment support.

Scope
U.S. hospital purchasing
Materiality
high
high

Financing and liquidity risk

The company has not yet generated enough cash from operations to fund growth.

Scope
Capital markets access
Materiality
high
medium

Competitive and technological change

The medical device market changes quickly and larger competitors may offer alternatives.

Scope
Interventional oncology devices
Materiality
high
medium

Supply-chain and cybersecurity disruption

The company relies on third parties for manufacturing, systems, and clinical operations.

Scope
Manufacturers, cloud systems, and contractors
Materiality
medium
Revenue recognition on consignment and direct sales
Can shift revenue between periods
Customer rebates
Reduces net sales and can affect quarterly comparability
Fair value of SEPA, warrant, and earnout liabilities
Can materially affect reported net loss
Manufacturing cost and inventory estimates
Affects gross margin and operating leverage

RenovoRx, Inc.

RNXT · Pharmaceutical Preparations

Penumbra Inc

PEN · Surgical & Medical Instruments & Apparatus

Edwards Lifesciences Corp

EW · Orthopedic, Prosthetic & Surgical Appliances & Supplies

InfuSystem Holdings, Inc

INFU · Surgical & Medical Instruments & Apparatus

Stereotaxis, Inc.

STXS · Electromedical & Electrotherapeutic Apparatus

GLOBUS MEDICAL INC

GMED · Surgical & Medical Instruments & Apparatus

: 29/04/2026